Abstract 14308: Treatment Patterns of Discontinuation in New Users of Oral Anticoagulants (OACs) in Patients With Non-Valvular Atrial Fibrillation (NVAF): Real-Word Evidence From NAXOS French Study

Nicolas Danchin,Isabelle Mahé,Olivier Hanon,Philippe Gabrie Steg,Bruno Falissard,Manon Belhassen,F. Jacoud,Maeva Nolin,M. Ginoux,F. Dalon,Cinira Lefevre,F.E. Cotté,S. Gollety,Eric Van Ganse

Abstract 14308: Treatment Patterns of Discontinuation in New Users of Oral Anticoagulants (OACs) in Patients With Non-Valvular Atrial Fibrillation (NVAF): Real-Word Evidence From NAXOS French Study

2019

Nicolas Danchin
Isabelle Mahé
Olivier Hanon
Philippe Gabrie Steg
Bruno Falissard
Manon Belhassen
F. Jacoud
Maeva Nolin
M. Ginoux
F. Dalon
Cinira Lefevre
F.E. Cotté
S. Gollety
Eric Van Ganse

Background: Oral anticoagulants (OACs) reduce the risk of thromboembolic events in NVAF patients. Discontinuation of treatment may expose NVAF patients to an increased risk of stroke. The respectiv...

Keywords:

increased risk
Internal medicine
real word
Discontinuation
Atrial fibrillation
Stroke
non valvular atrial fibrillation
in patient
Cardiology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations